SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-254169
Filing Date
2010-11-09
Accepted
2010-11-09 16:19:11
Documents
6
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 616647
2 ASSET PURCHASE AGREEMENT dex101.htm EX-10.1 199169
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 6705
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 7628
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - SECTION 906 dex321.htm EX-32.1 4318
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SECTION 906 dex322.htm EX-32.2 4277
  Complete submission text file 0001193125-10-254169.txt   840158
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 101176479
SIC: 2834 Pharmaceutical Preparations